"The recent launch of our leading posterior cervical fusion solution, Reline Cervical, and our annual meeting sponsorship of a preeminent cervical society, CSRS, underscores our shared belief in further advancing cervical technology," said
NuVasive will host two workshops on
NuVasive booth #105/204 will feature the Company's full C360™ portfolio, made up of best-in-class access instrumentation, implants, biologic materials, and enabling technologies within Pulse® for the anterior and posterior cervical spine.
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, among others, risks associated with acceptance of the Company's surgical products and procedures by spine surgeons and hospitals, development and acceptance of new products or product enhancements, clinical and statistical verification of the benefits achieved via the use of NuVasive's products, the Company's ability to adequately manage inventory as it continues to release new products, its ability to recruit and retain management and key personnel, and the other risks and uncertainties described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvasive-to-sponsor-and-participate-at-the-cervical-spine-research-society-50th-annual-meeting-301676684.html
Investor contact: Juliet C. Cunningham, NuVasive, Inc., 858-210-2129, firstname.lastname@example.org, Media contact: Melanie Ordoñez, NuVasive, Inc., 858-722-3899, email@example.com